BioSpace News Archive

Business

Evaxion Biotech Announces Second Quarter 2022 Financial Results and Provides Business Update

Evaxion Biotech A/S announced today its second quarter 2022 financial results and provided an operational and business update.

August 10, 2022
·
9 min read
Business

Tango Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Highlights

Tango Therapeutics, Inc. reported its financial results for the second quarter ended June 30, 2022 and provided business highlights.

August 10, 2022
·
13 min read
Business

PolyPid Provides Corporate Update and Reports Second Quarter 2022 Financial Results

PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today provided a corporate update and reported financial results for the three and six months ended June 30, 2022.

August 10, 2022
·
10 min read
BioMidwest

ELIAS Animal Health Research Demonstrates Cancer-Killing Capabilities of Its Activated T Cell Immunotherapy

ELIAS Animal Health recently presented new mechanism of action data for the ELIAS Cancer Immunotherapy at the 2022 American College of Veterinary Internal Medicine Forum.

August 10, 2022
·
2 min read
Genetown

GentiBio Announces Collaboration with Bristol Myers Squibb to Pioneer Engineered Treg Therapies for Inflammatory Bowel Diseases

GentiBio, Inc., an engineered regulatory T cells (Tregs) company, announced today that it has entered into a collaboration with Bristol Myers Squibb to develop new engineered Treg therapies to re-establish immune tolerance and repair tissue in patients living with inflammatory bowel diseases (IBD).

August 10, 2022
·
3 min read
Business

Sharecare announces second quarter 2022 financial results and operational highlights

Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced financial results for the quarter ended June 30, 2022.

August 10, 2022
·
17 min read
Business

Xeris Biopharma Reports Second Quarter Financial Results and Upcoming Events

Xeris Biopharma Holdings, Inc. today announced financial results for the second quarter and six months ended June 30, 2022 and upcoming events.

August 10, 2022
·
11 min read
Deals

Rapid Dose Therapeutics Announces Closing of First Tranche of Private Placement

Rapid Dose Therapeutics Corp. today announced that it has closed on $230,000 in a first tranche of its previously announced (May 26, 2022) private placement financing (the “ Financing ”) for up to $5,000,000 of gross proceeds, consisting of up to 5,000 units (the “ Units ”) at a price of $1,000 per Unit.

August 10, 2022
·
5 min read
Business

Adicet Reports Second Quarter 2022 Financial Results and Provides Business Updates

Adicet Bio, Inc. today reported financial results and operational highlights for the second quarter ended June 30, 2022.

August 10, 2022
·
10 min read
Genetown

Dyne Therapeutics Announces “Breakthrough Article” Publication of Duchenne Muscular Dystrophy Program Data in Nucleic Acids Research

Dyne Therapeutics, Inc. today announced the publication of Duchenne muscular dystrophy (DMD) preclinical data in a “Breakthrough Article” in Nucleic Acids Research, an honor reserved for approximately two percent of its accepted articles.

August 10, 2022
·
6 min read